Michael C Sofia

from Buffalo, NY

Age ~38

Get Report

Michael Sofia Phones & Addresses

Buffalo, NY

Resumes

Lifeguard

View page

Work:

Slpoa
Lifeguard

Michael Sofia

View page

Latest News

News

Researchers race to develop antiviral weapons to fight the pandemic coronavirus

View page

This is going to take time, says Michael Sofia, a chief scientific officer with Arbutus Biopharma, a Canadian antiviral company. And money. According to recent estimates, bringing a new drug to market costs between $985 million and $2.8 billion. Anderson says Pfizer, for one, is committing company

Date

Mar 11, 2021

Category:

More news

Source:

Google

Inventor of Hepatitis C Cure Wins a Major Prize—and Turns to the Next Battle

View page

and the debate cast a pall over the drugs release. But the medical featcreating this unprecedented weapon against hepatitis Chas scooped up accolades including the announcement Tuesday that its creator, Michael Sofia, has netted a prestigious Lasker Award for revolutionizing hepatitis C care. Laske

Date

Sep 13, 2016

Category:

Health

Source:

Google

Lasker prizes recognize oxygen discovery, hepatitis C treatment, and a lifetime of DNA research

View page

Work on the cure for HCVby Ralf Bartenschlager of the University Hospital Heidelberg in Germany, Charles Rice of The Rockefeller University in New York City, Michael Sofia of Arbutus Biopharma, headquartered in Barnaby, Canadareceived the Lasker Foundations clinical research award.

Date

Sep 13, 2016

Category:

Health

Source:

Google

Senators rip Gilead over its drug prices

View page

Gilead bought Pharmasset Inc. for $11 billion in 2011 to get its hepatitis compounds. One of the inventors of Sovaldi is Bucks County researcher Michael Sofia, who helped found Arbutus Biopharma after leaving Gilead.

Date

Dec 02, 2015

Source:

Google

Tekmira Pharma (TKMR), OnCore Biopharma Enter Merger Agreement

View page

approach to identifying the most effective combination regimens, while applying what we learn at each stage to optimize future compounds and combinations," said Dr. Michael Sofia, the combined company's Chief Scientific Officer and an inventor of sofosbuvir (Sovaldi) for the treatment of hepatitis C.

Date

Jan 12, 2015

Category:

Business

Source:

Google